Authors:
Modesitt, SC
Ramirez, P
Zu, ZF
Bodurka-Bevers, D
Gershenson, D
Wolf, JK
Citation: Sc. Modesitt et al., In vitro and in vivo adenovirus-mediated p53 and p16 tumor suppressor therapy in ovarian cancer - See The Biology Behind: M. E. Murphy, the battle between tumor suppressors: Is gene therapy using p16(INK4a) more efficacious than p53 for treatment of ovarian carcinoma? Clin. Cancer Res., 7: 1487-1489, 2001., CLIN CANC R, 7(6), 2001, pp. 1765-1772
Authors:
Hortobagyi, GN
Ueno, NT
Xia, WY
Zhang, S
Wolf, JK
Putnam, JB
Weiden, PL
Willey, JS
Carey, M
Branham, DL
Payne, JY
Tucker, SD
Bartholomeusz, C
Kilbourn, RG
De Jager, RL
Sneige, N
Katz, RL
Anklesaria, P
Ibrahim, NK
Murray, JL
Theriault, RL
Valero, V
Gershenson, DM
Bevers, MW
Huang, L
Lopez-Berestein, G
Hung, MC
Citation: Gn. Hortobagyi et al., Cationic liposome-mediated E1A gene transfer to human breast and ovarian cancer cells and its biologic effects: A phase I clinical trial, J CL ONCOL, 19(14), 2001, pp. 3422-3433
Authors:
Levenback, C
Coleman, RL
Burke, TW
Bodurka-Bevers, D
Wolf, JK
Gershenson, DM
Citation: C. Levenback et al., Intraoperative lymphatic mapping and sentinel node identification with blue dye in patients with vulvar cancer, GYNECOL ONC, 83(2), 2001, pp. 276-281
Authors:
Donato, ML
Gershenson, DM
Wharton, JT
Ippoliti, CM
Aleman, AS
Bodurka-Bevers, D
Bevers, MW
Burke, TW
Levenback, CF
Wolf, JK
Freedman, RS
Bast, RC
Gajewski, JL
Champlin, RE
Citation: Ml. Donato et al., High-dose topotecan, melphalan, and cyclophosphamide (TMC) with stem cell support: A new regimen for the treatment of advanced ovarian cancer, GYNECOL ONC, 82(3), 2001, pp. 420-426
Authors:
Robinson, JB
Singh, D
Bodurka-Bevers, DC
Wharton, JT
Gershenson, DM
Wolf, JK
Citation: Jb. Robinson et al., Hypersensitivity reactions and the utility of oral and intravenous desensitization in patients with gynecologic malignancies, GYNECOL ONC, 82(3), 2001, pp. 550-558
Authors:
Munkarah, A
Levenback, C
Wolf, JK
Bodurka-Bevers, D
Tortolero-Luna, G
Morris, RT
Gershenson, DM
Citation: A. Munkarah et al., Secondary cytoreductive surgery for localized intra-abdominal recurrences in epithelial ovarian cancer, GYNECOL ONC, 81(2), 2001, pp. 237-241
Citation: V. Dorfman et Jk. Wolf, Offset invariance in maximum-likelihood decoding for a class of partial response channels, IEEE COMM L, 4(7), 2000, pp. 229-230
Authors:
Ramondetta, L
Mills, GB
Burke, TW
Wolf, JK
Citation: L. Ramondetta et al., Adenovirus-mediated expression of p53 or p21 in a papillary serous endometrial carcinoma cell line (SPEC-2) results in both growth inhibition and apoptotic cell death: Potential application of gene therapy to endometrial cancer, CLIN CANC R, 6(1), 2000, pp. 278-284
Citation: Lp. Parker et al., Adenoviral-mediated gene therapy with Ad5CMVp53 and Ad5CMVp21 in combination with standard therapies in human breast cancer cell lines, ANN CLIN L, 30(4), 2000, pp. 395-405
Authors:
Gordinier, ME
Ramondetta, LM
Parker, LP
Wolf, JK
Follen, M
Gershenson, DM
Bodurka-Bevers, D
Citation: Me. Gordinier et al., Survey of female gynecologic oncologists and fellows: Balancing professional and personal life, GYNECOL ONC, 79(2), 2000, pp. 309-314
Authors:
Bodurka-Bevers, D
Basen-Engquist, K
Carmack, CL
Fitzgerald, MA
Wolf, JK
de Moor, C
Gershenson, DM
Citation: D. Bodurka-bevers et al., Depression, anxiety, and quality of life in patients with epithelial ovarian cancer, GYNECOL ONC, 78(3), 2000, pp. 302-308
Citation: H. Sawaguchi et Jk. Wolf, Turbo decoding for high-rate concatenated parity-check codes on PRML channels, IEEE MAGNET, 36(5), 2000, pp. 2173-2175
Authors:
Brenner, AJ
Brush, LA
Martin, JS
Olsson, KY
Rentschler, PL
Wolf, JK
Citation: Aj. Brenner et al., The Huron River Watershed Council: Grassroots organization for holistic watershed management, WATER SCI T, 39(12), 1999, pp. 331-337
Authors:
Wolf, JK
Mills, GB
Bazzet, L
Bast, RC
Roth, JA
Gershenson, DM
Citation: Jk. Wolf et al., Adenovirus-mediated p53 growth inhibition of ovarian cancer cells is independent of endogenous p53 status, GYNECOL ONC, 75(2), 1999, pp. 261-266
Authors:
Wolf, JK
Kim, TE
Fightmaster, D
Bodurka, D
Gershenson, DM
Mills, G
Wharton, JT
Citation: Jk. Wolf et al., Growth suppression of human ovarian cancer cell lines by the introduction of a p16 gene via a recombinant adenovirus, GYNECOL ONC, 73(1), 1999, pp. 27-34